American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

OKYO Pharma Ltd

$1.59 -1.85% NASDAQ: OKYO · 15-min delayed

Public · NASDAQ: OKYO
4 employees

Visit website Follow

$85.0MMarket cap

4Employees

OKYONASDAQ

2022IPO

About OKYO Pharma Ltd

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · NASDAQ: OKYO
Employees: 4
IPO date: May 17, 2022
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: OKYO Nasdaq
SEC CIK: 1849296
SIC: 2836 Biological Products, (No Diagnostic Substances)

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow OKYO Pharma Ltd and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Market cap: $85.0M

NASDAQ: OKYO

$1.59 -1.85%

15-minute delayed · data by Polygon.io

Past year

$1.34 $3.27

52-week range

Market cap: $85.0M
Shares outstanding: 53.5M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: May 17, 2022

Market data by Polygon.io · prices are 15-minute delayed

Auto-generated

At a glance

Trading 51% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review OKYO Pharma Ltd.

Write a review